267 NL75 Pill: white, capsule/oblong, 18mm
The pill with imprint 267 NL75 (White, Capsule/Oblong, 18mm) has been identified as Indomethacin Extended-Release 75 mg and is used for Back Pain, Bursitis, Ankylosing Spondylitis, Bartter Syndrome, and Cluster Headaches. It belongs to the drug class Nonsteroidal anti-inflammatory drugs and is not a controlled substance.
Images for 267 NL75
Indomethacin Extended-Release
- Imprint
- 267 NL75
- Strength
- 75 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nonsteroidal anti-inflammatory drugs
- Pregnancy Category
- C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ingenus Pharmaceuticals, LLC
- Manufacturer
- Novast Laboratories, Ltd.
- National Drug Code (NDC)
- 50742-0234
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
corn starch,
povidone,
sodium lauryl sulfate,
magnesium silicate,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
ammonio methacrylate copolymer type A,
triethyl citrate,
gelatin,
titanium dioxide,
shellac,
ferrosoferric oxide,
potassium hydroxide
Note: Inactive ingredients may vary.
See also:
More about indomethacin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (211)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Nonsteroidal anti-inflammatory drugs
- Breastfeeding
Patient resources
- Indomethacin drug information
- Indomethacin rectal
- Indomethacin (Intravenous) (Advanced Reading)
- Indomethacin Capsules
- Indomethacin Extended-Release Capsules
- Indomethacin Suppositories
Other brands
Professional resources
- Indomethacin monograph
- Indomethacin (FDA)
- Indomethacin ER (FDA)
- Indomethacin Injection (FDA)
- Indomethacin Oral Suspension (FDA)
- Indomethacin Suppository (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.